| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.059 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |